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OBJECTIVES We sought to assess the impact of contrast injection and harmonic imaging, on the measure
by echocardiography of left ventricular (LV) remodeling.
BACKGROUND Left ventricular remodeling is a precursor of LV dysfunction, but the impact of contrast
injection and harmonic imaging on the accuracy or reproducibility of echocardiography is
unclear.
METHODS We prospectively collected LV images by using simultaneous methods. Then, LV volumes
were measured off-line, in blinded manner and in random order. The accuracy of echocar-
diography was determined in comparison to electron beam computed tomography (EBCT)
in 26 patients. The reproducibility of echocardiography was assessed by three blinded
observers with different training levels in 32 patients.
RESULTS End-diastolic volume (EDV), end-systolic volume (ESV), stroke volume (SV) and ejection
fraction (EF), as measured by EBCT (195 6 55, 58 6 24 and 137 6 35 ml and 71 6 5%,
respectively) and echocardiography with harmonic imaging and contrast injection (194 6 51,
55 6 20 and 140 6 35 ml and 72 6 4%, respectively), showed no differences (all p . 0.15)
and excellent correlations (all r . 0.87). In contrast, echocardiography using harmonic
imaging without contrast injection underestimated the EBCT results (all p , 0.01).
Reproducibility was superior with rather than without contrast injection for intraobserver and
interobserver variabilities (all p , 0.001). Values measured by different observers were
different without contrast injection, but were similar with contrast injection (all p . 0.18).
Consequently, intrinsic patient differences represented a larger and almost exclusive propor-
tion of global variability with contrast injection for EDV (94 vs. 79%), ESV (93 vs. 82%), SV
(87 vs. 53%) and EF (84 vs. 41%), as compared with harmonic imaging without contrast
injection (all p , 0.005).
CONCLUSIONS For assessment of LV remodeling, echocardiography with harmonic imaging and contrast
injection improved the accuracy and reproducibility, as compared with imaging with-
out contrast injection. With contrast injection, variability was almost exclusively due to
intrinsic patient differences. Therefore, when evaluation of LV remodeling is deemed
important, assessment after contrast injection should be the preferred echocardiographic ap-
proach. (J Am Coll Cardiol 2001;38:867–75) © 2001 by the American College of
Cardiology
Cardiac remodeling is defined clinically as changes in the
size, shape and function of the heart, resulting from cardiac
load or injury (1). Uncontrolled left ventricular (LV) remod-
eling is part of a vicious cycle associated with progression of
LV dysfunction, with a poor prognosis, regardless of the
symptoms or cause (2–7). Therefore, accurate assessment of
the degree and progression of LV remodeling is integral to
the clinical evaluation of patients with LV overload or
dysfunction.
Measurement of LV size (end-diastolic volume [EDV]
and end-systolic volume [ESV]) and ejection phase indexes
(stroke volume [SV] and ejection fraction [EF]) is essential
to monitor LV remodeling. Because relatively small in-
creases in ventricular volume are associated with major
independent increases in the mortality risk of coronary
disease (6,8,9), valvular disease (2–5) or idiopathic heart
failure (7), accurate and reproducible assessment of LV
volume is crucial. Left ventricular diameters are used as
surrogates for LV volumes, but their measurement is
fraught with wide uncertainty regarding the assessment of
LV size, especially for enlarged ventricles (10).
Although selective angiography was the initial method
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for measurement of LV volumes (6,8), its small but definite
risk makes it unsuitable for serial assessment. Thus, echo-
cardiography is used for serial assessment of LV remodeling
in routine clinical practice. However, previous studies sug-
gest that echocardiography may underestimate LV volume
(11) and may be poorly reproducible (12,13). High-
resolution imaging and advanced expertise may overcome
these limitations in selected centers with experienced ob-
servers (14). Nevertheless, echocardiographic LV volumes
are rarely measured in routine practice, and because of their
uncertain accuracy and reproducibility, they have rarely been
used as end points in major LV remodeling clinical trials
such as Survival And Ventricular Enlargement (15) or
Studies Of Left Ventricular Dysfunction (16).
Recent imaging advances may improve echocardiographic
assessment of LV remodeling (17). Harmonic imaging
improves LV visualization (18) and injection of contrast
agents, although more costly and time-consuming, may
improve assessment of LV border and size (19). The
respective impacts of these technical improvements on the
accuracy and reproducibility of LV remodeling assessment
have not been evaluated, partly because of the lack of an
accurate reference method. However, electron beam com-
puted tomography (EBCT) provides an accurate reference
measurement of LV volumes and allows testing of the
hypothesis that the accuracy and reproducibility of echocar-
diographic assessment of LV volumes are improved by
adding contrast injection to harmonic imaging.
METHODS
General study design. The study was institutionally
funded and approved by the Institutional Review Board.
After the patients gave written, informed consent, a periph-
eral intravenous catheter was inserted, and LV echocardio-
graphic imaging was performed before and after intravenous
injection of a contrast agent and digitally stored. After
completion of the study, the saved cardiac cycles were
retrieved, assigned a predefined random number and then
analyzed in blinded, random order in duplicate. Inclusion
criteria were: 1) patients with LV remodeling due to isolated
mitral regurgitation (at least mild) or LV dysfunction, or
both; and 2) imaging of the LV from apical views, possible
but of any quality. Exclusion criteria were: 1) previous valve
replacement or repair; 2) mitral stenosis; 3) ruptured papil-
lary muscles; 4) aortic valve disease; 5) allergy to blood
products or to contrast material; 6) religious or other beliefs
precluding the use of human albumin products; 7) preg-
nancy or breast-feeding; and 8) no venous access.
No patient was excluded on the basis of age, gender, race,
heart rate or rhythm or image quality. The study, because of
its time-consuming nature, was conducted in two parts—
accuracy and reproducibility—and patients participated in
either part, but not in both of these parts, according to
availability.
Two-dimensional Doppler echocardiographic methods.
A complete two-dimensional Doppler echocardiographic
examination was performed. The LV was imaged in the
orthogonal apical views using harmonic imaging (1.7 MHz
to transmit, 3.5 MHz to receive), without and then with
contrast injection (Optison). The apical views of the LV
(four-chamber and either two-chamber or long-axis views)
were acquired and stored digitally (Acuson Sequoia, Moun-
tain View, California). After completion of all echocardio-
grams, the images with and without contrast injection were
assigned random numbers and analyzed by observers who
had no knowledge of the patients’ identification, clinical
data and previous results. Each observer computed EDV,
ESV, SV and EF by tracing the LV contours where they
visualized the endocardial border, as recommended by the
American Society of Echocardiography (20). Tracing of
LV contour left the papillary muscles and trabeculations
within the LV cavity, but otherwise was performed where
the blood-myocardial interface was seen (20). The LV
volumes were then calculated using the biplane Simpson’s
rule (method of disks) (20). Measurements were then
entered in the study data base by data-entry personnel not
involved in the study.
To define the reproducibility of echocardiography in 32
patients, LV contours were traced off-line from the digitally
retrieved cycles in random order by observers who had no
knowledge of the previous results and the patients’ identi-
fication. Three observers, with training levels 1, 2 and 3
(21,22), independently performed all measurements, which
were repeated a second time in a different random order by
each observer. To determine the accuracy of echocardiog-
raphy in 26 patients, LV echocardiographic images were
recorded and saved within 1 h before performance of an
EBCT of the heart. The LV contour tracings of the
echocardiographic images were performed in a blinded and
randomly ordered fashion after completion of the study.
Quantitation of mitral regurgitation was performed using
the quantitative Doppler (23) and proximal isovelocity
surface area (24) methods. Regurgitant volume and effective
regurgitant orifice were calculated (24,25).
Optison was administered intravenously in doses of
0.5 ml, followed by a saline flush. Additional doses, up to a
maximal dose of 3.0 ml, were given until the LV was
opacified with the contrast agent. Contrast injection images
were acquired using second-order harmonic imaging with
settings adjusted to reduce the mechanical index to 0.5 to
0.6 and with displacement of the transmit zone to the level
of the tips of the mitral valve leaflets.
Abbreviations and Acronyms
ANOVA 5 analysis of variance
EBCT 5 electron beam computed tomography
EDV 5 end-diastolic volume
EF 5 ejection fraction
ESV 5 end-systolic volume
LV 5 left ventricular
SV 5 stroke volume
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Electron beam computed tomography. Electron beam
computed tomography (Imatron C-150, South San Fran-
cisco, California) was performed using electrocardiographic
triggering for acquisition of polytomographic images at 17
frames/s. The subjects were positioned to acquire parallel
tomographic images in the short axis from the LV apex
through the left atrial roof. Infusion of a nonionic contrast
agent (iopamidol [Isovue-370]) was administered using a
power injector. With suspended respiration, an eight-level
ECG-triggered cine sequence with 8-mm-thick slices was
obtained. The identical sequence was repeated after reposi-
tioning to obtain a total of 16 levels covering the entire
cardiac span. Cross-sectional tomographic images (360 3
360 matrix) were reconstructed using a filtered back-
projection algorithm and stored on optical disk. The LV
epicardial and endocardial surfaces were identified during
contrast enhancement (26) and traced for each slice, with
LV volumes calculated using the modified Simpson’s rule
(27).
Statistical analysis. The results are expressed as the mean
value 6 SD or percentages, as appropriate. Comparison of
echocardiography and EBCT was based on paired t tests.
Comparison of the relative accuracy of the methods (echo-
cardiography vs. EBCT) was done using paired t tests with
unsigned differences (absolute and relative) between echo-
cardiography and EBCT.
Intraobserver variability of the echocardiographic meth-
ods was compared by submitting unsigned differences (ab-
solute and relative) between replicate readings for each
observer for each modality to three-way analysis of variance
(ANOVA) (patient by modality by observer) and by esti-
mating and testing the main effects of each patient, observer
and modality on intraobserver differences. To analyze inter-
observer variability, replications for each observer were
averaged, and the sample variance (s2) of these averages
within each patient across modalities was calculated. The
s values were then submitted to two-way ANOVA (patient
by modality), and the main effects of each patient and
modality were estimated and tested. Analysis was repeated
on a relative standard deviation, defined as standard devia-
tion divided by the mean value. Finally, to estimate the
components of global variability, the original data of each
modality were submitted to three-level nested ANOVA,
with replication nested within observer, nested within pa-
tient. A formal comparison was carried out on the basis of
ratios between patient variance and intraobserver or inter-
observer variance. The difference of the logarithm of the
ratio of mean square values was calculated, with standard
error based on an asymptotic calculation using the chi-
square distribution, and assumed independence between all
mean square values. Because mean square values are almost
certainly positively correlated between modalities, this pro-
cedure is conservative, but all pairwise comparisons turned
out to be significant (p , 0.05).
RESULTS
Baseline characteristics. The baseline characteristics were
similar for patients participating in the accuracy (n 5 26,
58% male, 68 6 14 years old) and reproducibility (n 5 32,
66% male, 66 6 14 years old) parts of the study. In the
accuracy and reproducibility subsets, New York Heart
Association functional class was I or II in 100% and 88%,
respectively. The LV end-diastolic and end-systolic diam-
eters and EF by M-mode echocardiography were 58 6
6 mm, 34 6 5 mm and 68 6 6%, respectively, in the
accuracy subset and 56 6 7 mm, 39 6 10 mm and 58 6
11%, respectively, in the reproducibility subset. Trivial
aortic regurgitation was present in 8% and 6% of the
accuracy and reproducibility subsets, respectively. The mean
regurgitant volume and effective regurgitant orifice showed
notable mitral regurgitation in the accuracy (71 6 21 ml and
35 6 11 mm2) and reproducibility (32 6 42 ml and 24 6
27 mm2) subsets. The systolic and diastolic blood pressure
and heart rate were within the normal range in the accuracy
(142 6 19 mm Hg and 75 6 12 mm Hg and 64 6
10 beats/min) and reproducibility (138 6 28 mm Hg and
80 6 12 mm Hg and 71 612 beats/min) subsets. No side
effects from contrast injection were observed in any of the
patients.
Accuracy of absolute LV volumes. Compared with
EBCT, echocardiography without contrast injection leads
to marked underestimation of EDV, ESV and SV (all p ,
0.0001) (Table 1). The magnitude of underestimation was
76 6 30 ml, 18 6 17 ml and 58 6 20 ml, respectively, for
EDV, ESV and SV, or 39%, 31% and 42% in relative terms.
There was no significant underestimation for EDV, ESV or
SV measured with contrast injection (all p . 0.17) (Table
1), with the regression line almost superimposed on the
identity line (all r . 0.87) (Figs. 1A, 2A and 3A). The
systematic difference in accuracy of EDV, ESV and SV by
echocardiography with and without contrast injection was
Table 1. Echocardiographic Assessment of Left Ventricular Volumes: Comparison With EBCT
EDV (ml) ESV (ml) SV (ml) EF (%)
EBCT 195 6 55 58 6 24 137 6 35 71 6 5
Echocardiography without contrast injection 119 6 34 40 6 16 79 6 24 68 6 7
p value vs. EBCT , 0.0001 , 0.0001 , 0.0001 0.011
Echocardiography with contrast injection 194 6 51 55 6 20 140 6 35 72 6 4
p value vs. EBCT 0.96 0.17 0.26 0.15
Data are presented as the mean value 6 SD.
EBCT 5 electron beam computed tomography; EDV 5 end-diastolic volume; EF 5 ejection fraction; ESV 5 end-systolic volume; SV 5 stroke volume.
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confirmed by Bland-Altman plots (Figs. 1B, 2B and 3B).
The unsigned (absolute value) differences between echocar-
diography and EBCT (expressed in original units or as a
percentage of EBCT values) were significantly lower with
than without contrast injection for EDV, ESV and SV (all
p , 0.001), confirming the superiority of the results
obtained by using contrast injection.
The EF obtained by echocardiography without contrast
injection was lower than that obtained by EBCT (68 6 7%
vs. 71 6 5%, p 5 0.011)—an underestimation by 3 6 6
points, or 4% in relative terms—whereas the EF by echo-
cardiography with contrast injection was not different from
that by EBCT (72 6 4%, p 5 0.15). Unsigned differences
between echocardiography and EBCT for EF were lower
with than without contrast injection (both p , 0.03).
Compared with the total SV measured by Doppler, the
LV SV showed marked underestimation when measured
without contrast injection (269 6 26 ml, p , 0.0001), but
no significant difference with contrast injection (28 6
25 ml, p 5 0.12).
Reproducibility. Intraobserver variability (Table 2, upper
rows) decreased by measuring LV volumes after contrast
injection, whether expressed in absolute (p , 0.004 for
EDV, ESV and SV; p 5 0.1 for EF) or relative (p , 0.05
for EDV, SV and EF) values. The other components of
ANOVA showed significant patient effects (p , 0.005 for
Figure 1. The impact of contrast injection on the assessment of left ventricular remodeling. (A) Scatterplot of end-diastolic volume (EDV) measured with
electron beam computed tomography (EBCT) (x axis) and echocardiography (Echo) (y axis) with (solid circles) and without (open triangles) contrast
injection. The solid lines represent the regression lines between each echocardiographic modality and EBCT. The dashed line represents the identity line.
(B) Scatterplot of the differences (y axis) in EDV between EBCT and echocardiography with contrast injection (solid circle) and between EBCT and
echocardiography without contrast injection (open triangles). The thick solid line and the two thin lines indicate the mean value and 95% confidence
interval of the difference between EBCT and echocardiography with contrast injection. Note the wide scatter of differences without contrast injection.
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EDV, ESV and SV; p 5 0.3 for EF) and mostly nonsig-
nificant observer effects (p . 0.07 for EDV, SV and EF;
p 5 0.03 for ESV). There was no interaction between the
experience of the observer and the decline in intraobserver
variability (all p . 0.10). When harmonic imaging was
compared with fundamental imaging, there was a trend
toward lower intraobserver variability for EDV (15 vs.19 ml,
p 5 0.10) and ESV (13 vs.16 ml, p 5 0.09), but no
significant difference for SV (16 vs. 14 ml, p 5 0.43) or EF
(6% vs. 6%, p 5 0.99).
Interobserver variability (Table 2, lower rows) decreased
by measuring LV volumes after contrast injection, whether
expressed in absolute (all p , 0.001) or relative (p , 0.01
for EDV, SV and EF) values. The other component of
ANOVA showed mostly nonsignificant patient effects (p .
0.20 for EDV, SV and EF; p 5 0.05 for ESV). Of note, the
EDV, SV and EF values obtained by the three observers
were significantly different when using harmonic imaging
alone (all p , 0.002) (with a trend toward a difference in
ESV, p 5 0.10), whereas all values obtained with contrast
injection were not different (all p . 0.18). When harmonic
imaging was compared with fundamental imaging, interob-
server variability was not different for EDV (22 vs. 24 ml,
p 5 0.53) or SV (22 vs. 25 ml, p 5 0.24), but was reduced
for ESV (14 vs. 21 ml, p 5 0.0001) and EF (8% vs. 11%,
p 5 0.02).
Global variability. The distribution of global variability of
the dependent variables (EDV, ESV, SV and EF) is
Figure 2. The impact of contrast injection on the assessment of left ventricular remodeling. (A) Scatterplot of end-systolic volume (ESV) measured with
electron beam computed tomography (EBCT) (x axis) and echocardiography (Echo) (y axis) with (solid circles) and without (open triangles) contrast
injection. The solid lines represent the regression lines between each echocardiographic modality and EBCT. The dashed line represents the identity line.
(B) Scatterplot of differences (y axis) in ESV between EBCT and echocardiography with contrast injection (solid circles) and between EBCT and
echocardiography without contrast injection (open triangles). The thick solid line and the two thin lines indicate the mean value and 95% confidence
interval of the difference between EBCT and echocardiography with contrast injection.
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composed of variability due to observers (intraobserver and
interobserver), variability due to intrinsic differences be-
tween patients (reflecting the breadth of values between
patients) and variability due to random error. A perfect
method results in 100% of variability related to intrinsic
patient differences. Nested ANOVA, used to analyze com-
ponents of global variability, showed highly significant
components for patient variability (all p , 0.0001) and
observer variability (all p , 0.006). Compared with mea-
surements without contrast injection, variability compo-
nents due to observer and random error were significantly
reduced with contrast injection (Table 3). Of note, mea-
surement of LV volumes with contrast injection was asso-
ciated with global variability due almost entirely to intrinsic
patient differences (94% for EDV, 93% for ESV, 87% for
SV and 84% for EF).
DISCUSSION
The present study shows that the addition of intravenous
contrast injection results in improved accuracy and repro-
ducibility of assessment of LV remodeling when compared
with state-of-the-art echocardiography using harmonic im-
aging. In comparison to simultaneous EBCT, the accuracy
of echocardiography for assessment of LV volumes is
markedly improved, without underestimation. With the
random-assignment design of the present study, the use of
contrast injection results in a marked decrease in intraob-
Figure 3. The impact of contrast injection on the assessment of left ventricular remodeling. (A) Scatterplot of stroke volume (SV) measured with electron
beam computed tomography (EBCT) (x axis) and echocardiography (Echo) (y axis) with (solid circles) and without (open triangles) contrast injection.
The solid lines represent the regression lines between each echocardiographic modality and EBCT. The dashed line represents the identity line. (B)
Scatterplot of differences (y axis) in SV between EBCT and echocardiography with contrast injection (solid circles) and between EBCT and
echocardiography without contrast injection (open triangles). The thick solid line and the two thin lines indicate the mean value and 95% confidence
interval of the difference between EBCT and echocardiography with contrast injection. Note the wide scatter of differences without contrast injection.
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server and interobserver variabilities for measurement of LV
volume, SV and EF. Therefore, postcontrast injection
measures of LV remodeling show no significant difference
between observers with different levels of training and
experience. These improvements resulted in significant
changes in the distribution of variability, which, after
contrast injection, was due almost entirely due to intrinsic
patient differences.
LV remodeling: importance of accurate assessment. Left
ventricular remodeling predicts a poor prognosis in the
context of coronary disease (6,8,9), dilated cardiomyopathy
(7) and valvular heart disease (2–5). Regardless of the causal
disease, progression of LV remodeling leads to congestive
cardiac failure and increased mortality (2–9). In coronary
disease, LV remodeling may be influenced by medical
treatment, and nonresponders usually display a poor prog-
nosis (15). Similarly, in valvular disease, indications for
surgical repair are dependent on the degree and progression
of LV remodeling (2–5).
Clinically, assessment of LV remodeling requires at least
an accurate and reproducible measurement of size (EDV
and ESV) and systolic indexes (SV and EF). These simple
variables represent a minimal requirement before more
complex indexes can even be considered (28). Calculation of
EF by simplified methods is usually appropriate (10,13,29),
and measurement of LV volumes for that purpose is rarely
required, although it may be necessary with complex re-
gional wall motion abnormalities (20,30) or for detection of
small changes. However, measurement of LV volumes to
assess the degree and progression of LV remodeling is
indispensable. Insidious remodeling with LV dilation,
which usually precedes a decline in EF (7,31), has led to the
concept of aggressive and early treatment of LV remodeling
(3,31). This concept is applicable only if accurate detection
of mild LV remodeling is feasible. Small increases in LV
size are associated with a notable, independent increase in
mortality (2–9). Therefore, sensitive, accurate and repro-
ducible assessment of LV size is crucial in risk stratification
and clinical decision-making. M-mode LV diameters are
easy to measure as surrogates for LV volumes and have a
narrow range of error in estimating LV volumes when LV
size is close to normal. However, with increasing LV size, a
considerable range of error makes LV diameters of little use
for prediction of LV volume (10). Furthermore, the curvi-
linear relationship between diameter and volume means that
small increases in diameter may correspond to large in-
creases in volume in dilated ventricles (10). Therefore, with
a remodeled LV, it is essential to directly measure LV
volumes, rather than using imprecise and potentially mis-
leading surrogates.
Rationale for use of contrast injection for assessment of
LV volumes. Echocardiography has been used to assess LV
volume, but its accuracy and reproducibility have been
challenged (11), especially with poor image quality. Tech-
nological advances that improve endocardial definition,
second-order harmonic imaging and intravenous contrast
Table 2. Intraobserver and Interobserver Variabilities
EDV ESV SV EF
Abs.* %† Abs.* %† Abs.* %† Abs.* %†
Intraobserver variability
Echocardiography without contrast injection 15 9 13 14 16 19 6 13
Echocardiography with contrast injection 10 7 7 13 11 12 4 8
p Value 0.004 0.05 0.0004 0.64 0.007 0.001 0.1 0.006
Interobserver variability
Echocardiography without contrast injection 22 13 14 17 22 28 8 18
Echocardiography with contrast injection 12 8 8 15 8 9 4 6
p Value 0.001 0.01 0.0001 0.33 0.0001 0.0001 0.0001 0.0001
*Data are expressed as absolute values in milliliters for EDV, ESV and SV and in percentage points for EF. †Data are expressed as a percentage of the mean value.
Abbreviations as in Table 1.
Table 3. Components of Global Variability*: Impact of Adding Contrast Injection on the Relative Distribution of
Sources of Variability
Variability
Source EDV (%) ESV (%) SV (%)
Echocardiography without contrast injection
Patient factors 78.9 82.3 52.7 41.0
Observer factors 15.4 7.8 29.7 38.2
Random factors 5.8 9.9 17.6 20.8
Echocardiography with contrast injection
Patient factors 94.2 92.8 86.8 84.2
Observer factors 2.6 3.3 3.8 4.4
Random factors 3.1 3.9 9.4 11.4
p Value† 0.001 0.005 0.001 0.001
*Expressed as a percentage of the variability. †Comparison of distribution of variability sources between results with and without contrast injection.
Abbreviations as in Table 1.
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injection (32,33) have the potential to improve the accuracy
and reproducibility of assessment of LV volumes. Contrast
injection improves measurement of LV volumes, compared
with fundamental imaging alone (19). However, the current
state-of-the-art imaging using harmonic imaging decreases
side lobes and improves lateral resolution and endocardial
definition (18). Whether contrast injection provides any
further improvement may be questionable. Harmonic im-
aging may improve visualization of endocardial borders to
such an extent that the use of contrast agents, which is
costly, and inconvenient venous line placement may not be
required for accurate quantification of LV function.
The present study shows that, despite the use of state-
of-the-art harmonic imaging as a comparison standard,
contrast enhancement results in improved accuracy and
reduced intraobserver and interobserver variability for mea-
surement of LV volumes and EF. This improvement allows
observers with different levels of training to obtain similar
results, not different from the results obtained by the
reference method of EBCT, and decreases overall variability
to the point that it is essentially due to intrinsic patient
differences. Therefore, contrast enhancement is crucial for
assessment of LV remodeling and has important clinical
implications. The mechanism for this improvement with
contrast injection is directly related to ventricular anatomy.
The LV endocardial border is obscured by true myocardial
structures, trabeculations, irregularities and papillary mus-
cles (34), which, unlike artifacts and side lobes, are not
eliminated by harmonic imaging. Echocardiographic con-
trast agents that traverse the pulmonary circulation enhance
all blood-filled parts of the LV cavity and not only improve
LV imaging quality (35,36) but also delimit the true cavity
to the endocardial boundary (17).
Clinical implications. With contrast injection, observers
of all levels of expertise obtained similar and highly repro-
ducible assessment of LV remodeling. Therefore, reproduc-
ible and accurate LV volume measurement, which in the
past could be obtained using standard imaging in the hands
of experts (14,19), can now be achieved by nonexperts using
contrast injection and has the potential to result in more
frequent assessment of LV remodeling in routine practice.
The accurate assessment of LV remodeling using contrast
injection, in comparison to EBCT, is an essential improve-
ment over the shortcomings of M-mode echocardiographic
methods. The use of intravenous contrast injection is
essential for initial or serial assessment of LV volumes in
patients with an abnormal or dilated LV. In contrast, in
normal ventricles, assessment of LV size and function using
M-mode echocardiography is adequate (10). Therefore,
contrast injection is not necessary in all patients undergoing
echocardiography, but it is an important addition for the
appropriate measurement of LV volumes in patients in
whom LV dilation or remodeling is suspected, such as in
patients with cardiomyopathy, previous myocardial infarc-
tion or valvular heart disease.
Study limitations. The choice of the reference method can
be disputed. Measurements of LV volume and mass by
EBCT have been validated both in vivo and in vitro and
show very low interobserver and intraobserver variabilities
(26,27,37), allowing for follow-up of patients to detect LV
remodeling (38). Because EBCT assessment of LV volumes
is three-dimensional, noninvasive, accurate and reproduc-
ible, it serves as an ideal reference method for this study.
Measurements by experts may provide accurate LV vol-
umes without injection of contrast (14), but are not widely
applicable. The present study, by using observers who were
not experts and who had different levels of experience, is
widely applicable to routine echocardiography practice.
Importantly, the present study shows, under its stringent
methodology, that nonexperts of various levels can obtain
accurate, highly reproducible measures of LV remodeling,
and that the advantages provided by contrast injection are
widely applicable.
It is impossible to blind observers to the presence of
contrast agents on echocardiographic images, and this may
potentially introduce bias. However, as the observers were
totally blinded to each patient’s other results and to the
patients’ identity, with tracings done in totally random
order, the probability of bias is very low. Hence, the low
variability and high accuracy of LV volumes measured with
contrast injection underscore the value of this approach in
assessing LV remodeling.
Conclusions. The present study documents the improved
accuracy and reproducibility of LV volume measurements
when contrast injection is added to state-of-the-art second-
order harmonic imaging. With contrast injection, observers
with different levels of training and experience obtain
similar LV remodeling measurements, and the global vari-
ability of measurements is almost exclusively due to intrinsic
patient differences. Therefore, when evaluation of LV re-
modeling is deemed important, assessment after contrast
injection should be the preferred echocardiographic ap-
proach and has the potential to be widely applicable in
routine clinical practice.
Reprint requests and correspondence: Dr. Maurice Enriquez-
Sarano, Mayo Clinic, 200 First Street SW, Rochester, Minnesota
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